Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance. (Q37008210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Kline J

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Subbiah S

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Lazarus HM

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

19 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

505-513

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705931

27 December 2019

exact match

0 references

cites work

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Induction of graft-versus-host disease after autologous bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Autologous graft-versus-host disease after CD34+-purified autologous peripheral blood progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Abnormal differentiation of thymocytes in mice treated with cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Autologous peripheral blood stem cell transplantation with induction of autologous graft-versus-host disease in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Interferon-gamma potentiates the antitumor effect of cyclosporine-induced autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Vaccines in cancer: GVAX, a GM-CSF gene vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Effects of cyclosporine A on T cell development and clonal deletion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Autologous graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Roquinimex-induced graft-versus-host reaction after autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Induction of autologous graft-versus-host disease with cyclosporin A after peripheral blood stem cell transplantation: analysis of factors affecting induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Dermatologic changes associated with roquinimex immunotherapy after autologous bone marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705931

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705931

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18026144%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference